Nataliya McElroy, PharmD

home / authors / nataliya-mcelroy-pharmd

Articles

Site Logo

Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan Reexamination

Rajul A. Patel, PharmD, PhD;Mark P. Walberg, PharmD, PhD;Yvonne Mai, PharmD;Nataliya McElroy, PharmD;Anil Mallya, PharmD;Aesun Kim, PharmD;Justin Seo, PharmD;Joseph A. Woelfel, RPh, PhD
April 22nd 2015

Medicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.

Read More

Latest Updated Articles

MEDcast logo
Published: July 1st 2024 | Updated: September 18th 2024
Key Considerations for the Effective Utilization of RSV Vaccines
Non Small Cell Lung Cancer (NSCLC) in the lung tissue – closeup view 3d illustration
Published: September 9th 2024 | Updated: September 18th 2024
MARIPOSA Study Shows No Significant Differences Between Lazertinib and Osimertinib for NSCLC
Image Credit: ralwel - stock.adobe.com
Published: September 13th 2024 | Updated: September 18th 2024
FDA Approves Ocrevus Zunovo for 2 Forms of Multiple Sclerosis
Chronic lymphocytic leukemia -- Image credit: LASZLO | stock.adobe.com
Published: August 19th 2024 | Updated: September 18th 2024
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK Inhibitors
Image Credit: © Zhanna - stock.adobe.com
Published: September 4th 2024 | Updated: September 18th 2024
Insights Into Immunotherapies For Adults With TP53-Mutated Acute Lymphoblastic Leukemia
Image Credit: © Gefo- stock.adobe.com
Published: September 7th 2024 | Updated: September 18th 2024
Expanding Treatment Horizons for Sickle Cell Disease: Barriers, Innovations, and Future Directions